Your browser doesn't support javascript.
loading
Lurasidone and risk for metabolic syndrome: results from short- and long-term clinical studies in patients with schizophrenia.
Tocco, Michael; Newcomer, John W; Mao, Yongcai; Pikalov, Andrei; Loebel, Antony.
Affiliation
  • Tocco M; Sunovion Pharmaceuticals Inc., Fort Lee, NJ, USA.
  • Newcomer JW; Thriving Mind, Miami, FL, USA.
  • Mao Y; Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
  • Pikalov A; Sunovion Pharmaceuticals Inc., Fort Lee, NJ, USA.
  • Loebel A; Sunovion Pharmaceuticals Inc., Fort Lee, NJ, USA.
CNS Spectr ; : 1-11, 2020 Sep 14.
Article in En | MEDLINE | ID: mdl-32921337
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Language: En Journal: CNS Spectr Journal subject: NEUROLOGIA Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Language: En Journal: CNS Spectr Journal subject: NEUROLOGIA Year: 2020 Document type: Article Affiliation country: Country of publication: